Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,985–2,992 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Novartis AG TOUR006 - (TRANQUILITY) Atherosclerotic cardiovascular disease (ASCVD) Phase 3 Trial Planned Intravenous Cardiology
Novartis AG Leqvio - (V-INITIATE) Low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease (ASCVD) Phase 3 Data Released Subcutaneous Cardiology
Novartis AG Zolgensma (onasemnogene abeparvovec) - (SMART) Spinal muscular atrophy (SMA) Phase 3 Data Released Intravenous infusion Genetic Disorder
Novartis AG Ianalumab - (NEPTUNUS-2) Sjögren’s syndrome Phase 3 Data Released Subcutaneous Immunology
Novartis AG Cosentyx - (REPLENISH) Polymyalgia rheumatica Phase 3 Data Released Subcutaneous #N/A
Novartis AG Leqvio - (V-Mono) CVRR (Primary prevention) Phase 3 Data Released Subcutaneous Cardiology
Novartis AG Leqvio - (ORION-13) Hyperlipidemia (pediatrics) Phase 3 Ongoing Subcutaneous Cardiology
Novartis AG Leqvio - (ORION-16) Hyperlipidemia (pediatrics) Phase 3 Ongoing Subcutaneous Cardiology